期刊文献+

基质金属蛋白酶及其组织抑制剂在糖尿病小鼠视网膜组织中的表达 被引量:11

The expression of matrix metalloproteinases and their tissue inhibitors in retinae of diabetic mice
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶(MMP-2、MMP-9)及其组织抑制剂(TIMP-2)在糖尿病视网膜病变(DRP)发生发展中的作用及其机制。方法:用免疫组织化学方法和计算机-图像分析技术研究C57BL/KsJdb/db糖尿病小鼠视网膜组织中MMP-2、MMP-9和TIMP-2的表达情况,并观察糖尿病小鼠视网膜毛细血管及其基底膜的超微结构改变,其db/+型同性同窝瘦型鼠为对照;用SAS软件对实验结果进行统计学处理。结果:随病程进展,糖尿病小鼠视网膜毛细血管基底膜进行性增厚,MMP-2和MMP-9在糖尿病小鼠视网膜组织中的表达显著性降低(P <0.05),而TIMP-2的表达显著性升高(P <0.05),同一病程阶段的MMP-2/TIMP-2的比值显著性降低(P <0.05)。结论:随着病程进展,由于TIMP-2表达的增高,通过与MMP-2以1:1的比例结合成复合物的形式抑制了MMP-2的活性,另外又有MMP-9的表达随病程进展显著下降,这可能是导致DRP早期视网膜毛细血管基底膜进行性增厚的原因。 AIM: To explore the role of MMP-2, MMP-9 and TIMP-2 in the development of DRP.· METHODS: Immunohistochemical technique and computer image-analysing instrument were used to analyse the expression of MMP-2,MMP-9 and TIMP-2 in the retinae of C57BL/KsJ db/db diabetic mice, their thin db/+ litters being normal controls.SAS was used to analyse the data.· RESULTS: As diabetes duration progressed, the retinal microvascular basement membrane of diabetic mice were thickened; The expression of MMP-2 and MMP-9 in the retinae of diabetic mice decreased significantly (P < 0.05); The expression of TIMP-2 increased significantly (P <0.05); The ratio of MMP-2/TIMP-2 at the same duration decreased significantly (P <0.05).· CONCLUSION: As diabetes duration progressed,the activation of MMP-2 are naturally inhibited by the 1:1 compound formation of MMP-2 and TIMP-2 due to the high level of TIMP-2. Moreover,the expression of MMP-9 decreased significantly. These may lead to the gradually thickened retinal microvascular basement membrane in the early DRP.·
作者 赵平 于华军
出处 《国际眼科杂志》 CAS 2004年第4期610-614,共5页 International Eye Science
关键词 基质金属蛋白酶 组织抑制剂 糖尿病 小鼠 视网膜组织 表达 matrix metalloproteinase-2 (MMP-2) matrix metalloproeinase-9(MMP-9) tissue inhibitor of metalloproteinase-2(TIMP-2) diabetic-retinopathy(DRP) immunohistochemistry
  • 相关文献

参考文献14

  • 1Still K, Robson CN, Autzen P, Robinson MC, Hamdy FC. Localization and quantification of mRNA for matrix metallo- proteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant protatic tissue.Prostate, 2000;
  • 2Ara T, Kusafuka T, Inoue M, Kuroda S, Fukuzawa M, Okada A. Determination of imbalance between MMP-2 and TIMP-2 in human neuroblasma by reverse-transcription polymerase chain reaction and its correlation with tumor progression.J Pediatr Surg,2000;35(3):432
  • 3Salzmann J, Limb GA, Khaw PT, Gregor ZJ, Webster L, Chignell AH,Charteris DG. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol,2000;10 (84):1091-1096
  • 4Lamoreaux WJ, Fitzgerald ME, Reiner A, Hasty KA, Charles ST. Vascular endothelial growth factor increase release of gelatinase A and decrease release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvas Res , 199
  • 5Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochem Biophys Acta, 2000;1477(1-2):267-283
  • 6Shafrir E. Animal models of non-insulin dependent diabetes. Diabetes Metab Rev, 1992;8:179-208
  • 7Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.Invest Ophthalmol Vis Sci, 2003;44(5):2163-2170
  • 8Sethi CS, Bailey TA, Luther PJ, Chong NH. Matrix metalloproteinase biology applied to vitreo retinal disorders. Br J Ophthalmol, 2000;6(84):654-666
  • 9Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE, Sang QX. Identification and characterization of human endometase(matrixmetallo proteinase-26) from endometrial tumer. J Biochem, 2000;275(27):20540-20544
  • 10Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase-4.J Biol Chem , 1996;271(48):30375-30380

同被引文献103

引证文献11

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部